Amended and Restated Second Technology Transfer and License Agreement (May 2nd, 2014)
Each Therapeutic Development Milestone shall be paid only once in connection with each Target. Dyax acknowledges the prior receipt of the milestone payment referred to in item (i) above with respect to Therapeutic Products directed to each of the Targets covered by the Previously Sublicensed CAT Product Licenses.
U.S. $50,000,000 LOAN AGREEMENT Dated as of August 5, 2008 Between (August 4th, 2009)
This LOAN AGREEMENT is dated as of August 5, 2008, by and between COWEN HEALTHCARE ROYALTY PARTNERS, L.P., a Delaware limited partnership (the Lender), as Lender and DYAX CORP., a Delaware corporation, as Borrower. The Lender and Borrower are hereinafter referred to collectively as the Parties or individually as a Party.